Ramelteon

被引：21

作者：

Buysse, D ^{[1
]}

Bate, G

Kirkpatrick, P

机构：

[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2005年 / 4卷 / 11期

关键词：

D O I：

10.1038/nrd1881

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Ramelteon (Rozerem; Takeda), a melatonin receptor agonist, was approved by the US FDA for the treatment of insomnia in July 2005. In contrast to other widely used drugs for this condition, it has shown no evidence of dependence or abuse potential, and has not been designated as a controlled substance.

引用

页码：881 / 882

页数：2

共 6 条

[1] Effects of exogenous melatonin on sleep: a meta-analysis [J].